New hepatitis C wonder drug shakes up the health care industry with remarkable success and $1,000/pill price
In December 2013, Sovaldi won approval from the U.S. Food and Drug Administration, and Roth, of San Rafael, Calif., was placed on a 24-week treatment regimen. The cost: $168,000, or an eye-popping $1,000 per pill. The company says Sovaldi’s price reflects its 90 percent-plus cure rate for hepatitis C and the savings that produces by cutting patients’ long-term treatment costs, which can include hospitalizations, surgeries and even liver transplants.
LATEST NEW HAMPSHIRE ANGLE
Slam thunk! Sarah Silverman nearly hit by basketball at Knicks game... but luckily John McEnroe is there to shield her
'Interview' buzz spreads to NH